People's United Financial’s Emergent Biosolutions EBS Stock Holding History

People's United Financial’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,595	Closed	-$232K	–	768
2019 Q1	$232K	Buy	4,595 +20	+0.4%	+$1.18K	0.01%	659
2018 Q4	$271K	Hold	4,575	–	–	0.01%	626
2018 Q3	$301K	Buy	+4,575	New	+$267K	0.01%	606

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

People's United Financial's EBS Position: Q2 2019 in Review

People's United Financial sold out of Emergent Biosolutions (EBS) in Q2 2019, closing a stake of 4,595 shares — an estimated $232K sold.

People's United Financial first reported a position in EBS in Q3 2018 and held it in 3 quarters. The position peaked at $301K in Q3 2018. 233 funds tracked by Wall St. Rank hold EBS as of Q2 2019.

People's United Financial reported no remaining Emergent Biosolutions position as of Q2 2019 after selling out during the quarter.
People's United Financial sold 4,595 Emergent Biosolutions shares in Q2 2019, an estimated $232K.
People's United Financial first reported a position in Emergent Biosolutions in Q3 2018 and held it in 3 quarters.
People's United Financial's Emergent Biosolutions position peaked at $301K in Q3 2018.
233 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2019.

Based on People's United Financial's 13F filing for Q2 2019, filed 14 Aug 2019.